These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16805952)

  • 1. Enhanced cellular uptake of Ara-C via a peptidomimetic prodrug, L-valyl-ara-C in Caco-2 cells.
    Cheon EP; Hong JH; Han HK
    J Pharm Pharmacol; 2006 Jul; 58(7):927-32. PubMed ID: 16805952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic characteristics of L-valyl-ara-C and its implication on the oral delivery of ara-C.
    Cheon EP; Han HK
    Acta Pharmacol Sin; 2007 Feb; 28(2):268-72. PubMed ID: 17241530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine.
    Sun Y; Sun J; Shi S; Jing Y; Yin S; Chen Y; Li G; Xu Y; He Z
    Mol Pharm; 2009; 6(1):315-25. PubMed ID: 19115956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
    Sawada K; Terada T; Saito H; Hashimoto Y; Inui KI
    J Pharmacol Exp Ther; 1999 Nov; 291(2):705-9. PubMed ID: 10525090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
    Han HK; Oh DM; Amidon GL
    Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.
    de Vrueh RL; Smith PL; Lee CP
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1166-70. PubMed ID: 9732374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of intestinal absorption of an orally active beta-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells.
    Li YH; Ito K; Tsuda Y; Kohda R; Yamada H; Itoh T
    J Pharmacol Exp Ther; 1999 Sep; 290(3):958-64. PubMed ID: 10454465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
    Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation.
    Brouwers J; Tack J; Augustijns P
    Int J Pharm; 2007 May; 336(2):302-9. PubMed ID: 17207947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
    Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
    J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations.
    Våbenø J; Nielsen CU; Ingebrigtsen T; Lejon T; Steffansen B; Luthman K
    J Med Chem; 2004 Sep; 47(19):4755-65. PubMed ID: 15341490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro biological evaluation of valine-containing prodrugs derived from clinically used HIV-protease inhibitors.
    Roche D; Greiner J; Aubertin AM; Vierling P
    Eur J Med Chem; 2008 Jul; 43(7):1506-18. PubMed ID: 17950955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
    Sinko PJ; Balimane PV
    Biopharm Drug Dispos; 1998 May; 19(4):209-17. PubMed ID: 9604120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of valacyclovir: implications for its oral bioavailability.
    Granero GE; Amidon GL
    Int J Pharm; 2006 Jul; 317(1):14-8. PubMed ID: 16759825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of free and peptide-bound pyrraline at intestinal and renal epithelial cells.
    Hellwig M; Geissler S; Peto A; Knütter I; Brandsch M; Henle T
    J Agric Food Chem; 2009 Jul; 57(14):6474-80. PubMed ID: 19555106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
    Gupta SV; Gupta D; Sun J; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2011 Dec; 8(6):2358-67. PubMed ID: 21905667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatography/tandem mass spectrometry method for the simultaneous determination of cytarabine and its valyl prodrug valcytarabine in rat plasma.
    Sun Y; Sun J; Wen B; Shi S; Xu Y; Chen Y; Wang Y; Pan C; Zhang C; Zhang T; He Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):121-5. PubMed ID: 18571482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
    Ichikawa H; Onishi H; Takahata T; Machida Y; Nagai T
    Drug Des Discov; 1993; 10(4):343-53. PubMed ID: 8148473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.